COVID-19 Impact on Global Post Herpetic Neuralgia Therapies Market Size, Status and Forecast 2020-2026
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Post Herpetic Neuralgia Therapies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Post Herpetic Neuralgia Therapies industry.
Based on our recent survey, we have several different scenarios about the Post Herpetic Neuralgia Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Post Herpetic Neuralgia Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post Herpetic Neuralgia Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post Herpetic Neuralgia Therapies market in terms of revenue.
Players, stakeholders, and other participants in the global Post Herpetic Neuralgia Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Post Herpetic Neuralgia Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Post Herpetic Neuralgia Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post Herpetic Neuralgia Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post Herpetic Neuralgia Therapies market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Post Herpetic Neuralgia Therapies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Post Herpetic Neuralgia Therapies industry.
Based on our recent survey, we have several different scenarios about the Post Herpetic Neuralgia Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Post Herpetic Neuralgia Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post Herpetic Neuralgia Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post Herpetic Neuralgia Therapies market in terms of revenue.
Players, stakeholders, and other participants in the global Post Herpetic Neuralgia Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Post Herpetic Neuralgia Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Post Herpetic Neuralgia Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post Herpetic Neuralgia Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post Herpetic Neuralgia Therapies market.
The following players are covered in this report:
- Endo Pharmaceuticals
- Depomed
- Acorda Therapeutics
- Pfizer
- Mylan
- Daiichi Sankyo
- Teikoku Pharma
- Drugs
- Patches
- Steroid Injectable
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Post Herpetic Neuralgia Therapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drugs
1.4.3 Patches
1.4.4 Steroid Injectable
1.5 Market by Application
1.5.1 Global Post Herpetic Neuralgia Therapies Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Post Herpetic Neuralgia Therapies Industry Impact
1.6.1 How the Covid-19 is Affecting the Post Herpetic Neuralgia Therapies Industry
1.6.1.1 Post Herpetic Neuralgia Therapies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Post Herpetic Neuralgia Therapies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Post Herpetic Neuralgia Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Post Herpetic Neuralgia Therapies Market Perspective (2015-2026)
2.2 Post Herpetic Neuralgia Therapies Growth Trends by Regions
2.2.1 Post Herpetic Neuralgia Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Post Herpetic Neuralgia Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Post Herpetic Neuralgia Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Post Herpetic Neuralgia Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Post Herpetic Neuralgia Therapies Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Post Herpetic Neuralgia Therapies Players by Market Size
3.1.1 Global Top Post Herpetic Neuralgia Therapies Players by Revenue (2015-2020)
3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio
3.2.1 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Post Herpetic Neuralgia Therapies Revenue in 2019
3.3 Post Herpetic Neuralgia Therapies Key Players Head office and Area Served
3.4 Key Players Post Herpetic Neuralgia Therapies Product Solution and Service
3.5 Date of Enter into Post Herpetic Neuralgia Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Post Herpetic Neuralgia Therapies Historic Market Size by Type (2015-2020)
4.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Type (2021-2026)
5 POST HERPETIC NEURALGIA THERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
5.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Post Herpetic Neuralgia Therapies Market Size (2015-2020)
6.2 Post Herpetic Neuralgia Therapies Key Players in North America (2019-2020)
6.3 North America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
6.4 North America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Post Herpetic Neuralgia Therapies Market Size (2015-2020)
7.2 Post Herpetic Neuralgia Therapies Key Players in Europe (2019-2020)
7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
7.4 Europe Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
8 CHINA
8.1 China Post Herpetic Neuralgia Therapies Market Size (2015-2020)
8.2 Post Herpetic Neuralgia Therapies Key Players in China (2019-2020)
8.3 China Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
8.4 China Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Post Herpetic Neuralgia Therapies Market Size (2015-2020)
9.2 Post Herpetic Neuralgia Therapies Key Players in Japan (2019-2020)
9.3 Japan Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
9.4 Japan Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Post Herpetic Neuralgia Therapies Market Size (2015-2020)
10.2 Post Herpetic Neuralgia Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
11 INDIA
11.1 India Post Herpetic Neuralgia Therapies Market Size (2015-2020)
11.2 Post Herpetic Neuralgia Therapies Key Players in India (2019-2020)
11.3 India Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
11.4 India Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Post Herpetic Neuralgia Therapies Market Size (2015-2020)
12.2 Post Herpetic Neuralgia Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
12.4 Central & South America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Endo Pharmaceuticals
13.1.1 Endo Pharmaceuticals Company Details
13.1.2 Endo Pharmaceuticals Business Overview and Its Total Revenue
13.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Introduction
13.1.4 Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020))
13.1.5 Endo Pharmaceuticals Recent Development
13.2 Depomed
13.2.1 Depomed Company Details
13.2.2 Depomed Business Overview and Its Total Revenue
13.2.3 Depomed Post Herpetic Neuralgia Therapies Introduction
13.2.4 Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.2.5 Depomed Recent Development
13.3 Acorda Therapeutics
13.3.1 Acorda Therapeutics Company Details
13.3.2 Acorda Therapeutics Business Overview and Its Total Revenue
13.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Introduction
13.3.4 Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.3.5 Acorda Therapeutics Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview and Its Total Revenue
13.4.3 Pfizer Post Herpetic Neuralgia Therapies Introduction
13.4.4 Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Mylan
13.5.1 Mylan Company Details
13.5.2 Mylan Business Overview and Its Total Revenue
13.5.3 Mylan Post Herpetic Neuralgia Therapies Introduction
13.5.4 Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.5.5 Mylan Recent Development
13.6 Daiichi Sankyo
13.6.1 Daiichi Sankyo Company Details
13.6.2 Daiichi Sankyo Business Overview and Its Total Revenue
13.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Introduction
13.6.4 Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.6.5 Daiichi Sankyo Recent Development
13.7 Teikoku Pharma
13.7.1 Teikoku Pharma Company Details
13.7.2 Teikoku Pharma Business Overview and Its Total Revenue
13.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Introduction
13.7.4 Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.7.5 Teikoku Pharma Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Post Herpetic Neuralgia Therapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drugs
1.4.3 Patches
1.4.4 Steroid Injectable
1.5 Market by Application
1.5.1 Global Post Herpetic Neuralgia Therapies Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Post Herpetic Neuralgia Therapies Industry Impact
1.6.1 How the Covid-19 is Affecting the Post Herpetic Neuralgia Therapies Industry
1.6.1.1 Post Herpetic Neuralgia Therapies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Post Herpetic Neuralgia Therapies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Post Herpetic Neuralgia Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Post Herpetic Neuralgia Therapies Market Perspective (2015-2026)
2.2 Post Herpetic Neuralgia Therapies Growth Trends by Regions
2.2.1 Post Herpetic Neuralgia Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Post Herpetic Neuralgia Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Post Herpetic Neuralgia Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Post Herpetic Neuralgia Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Post Herpetic Neuralgia Therapies Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Post Herpetic Neuralgia Therapies Players by Market Size
3.1.1 Global Top Post Herpetic Neuralgia Therapies Players by Revenue (2015-2020)
3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio
3.2.1 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Post Herpetic Neuralgia Therapies Revenue in 2019
3.3 Post Herpetic Neuralgia Therapies Key Players Head office and Area Served
3.4 Key Players Post Herpetic Neuralgia Therapies Product Solution and Service
3.5 Date of Enter into Post Herpetic Neuralgia Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Post Herpetic Neuralgia Therapies Historic Market Size by Type (2015-2020)
4.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Type (2021-2026)
5 POST HERPETIC NEURALGIA THERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
5.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Post Herpetic Neuralgia Therapies Market Size (2015-2020)
6.2 Post Herpetic Neuralgia Therapies Key Players in North America (2019-2020)
6.3 North America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
6.4 North America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Post Herpetic Neuralgia Therapies Market Size (2015-2020)
7.2 Post Herpetic Neuralgia Therapies Key Players in Europe (2019-2020)
7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
7.4 Europe Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
8 CHINA
8.1 China Post Herpetic Neuralgia Therapies Market Size (2015-2020)
8.2 Post Herpetic Neuralgia Therapies Key Players in China (2019-2020)
8.3 China Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
8.4 China Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Post Herpetic Neuralgia Therapies Market Size (2015-2020)
9.2 Post Herpetic Neuralgia Therapies Key Players in Japan (2019-2020)
9.3 Japan Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
9.4 Japan Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Post Herpetic Neuralgia Therapies Market Size (2015-2020)
10.2 Post Herpetic Neuralgia Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
11 INDIA
11.1 India Post Herpetic Neuralgia Therapies Market Size (2015-2020)
11.2 Post Herpetic Neuralgia Therapies Key Players in India (2019-2020)
11.3 India Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
11.4 India Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Post Herpetic Neuralgia Therapies Market Size (2015-2020)
12.2 Post Herpetic Neuralgia Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
12.4 Central & South America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Endo Pharmaceuticals
13.1.1 Endo Pharmaceuticals Company Details
13.1.2 Endo Pharmaceuticals Business Overview and Its Total Revenue
13.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Introduction
13.1.4 Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020))
13.1.5 Endo Pharmaceuticals Recent Development
13.2 Depomed
13.2.1 Depomed Company Details
13.2.2 Depomed Business Overview and Its Total Revenue
13.2.3 Depomed Post Herpetic Neuralgia Therapies Introduction
13.2.4 Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.2.5 Depomed Recent Development
13.3 Acorda Therapeutics
13.3.1 Acorda Therapeutics Company Details
13.3.2 Acorda Therapeutics Business Overview and Its Total Revenue
13.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Introduction
13.3.4 Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.3.5 Acorda Therapeutics Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview and Its Total Revenue
13.4.3 Pfizer Post Herpetic Neuralgia Therapies Introduction
13.4.4 Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Mylan
13.5.1 Mylan Company Details
13.5.2 Mylan Business Overview and Its Total Revenue
13.5.3 Mylan Post Herpetic Neuralgia Therapies Introduction
13.5.4 Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.5.5 Mylan Recent Development
13.6 Daiichi Sankyo
13.6.1 Daiichi Sankyo Company Details
13.6.2 Daiichi Sankyo Business Overview and Its Total Revenue
13.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Introduction
13.6.4 Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.6.5 Daiichi Sankyo Recent Development
13.7 Teikoku Pharma
13.7.1 Teikoku Pharma Company Details
13.7.2 Teikoku Pharma Business Overview and Its Total Revenue
13.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Introduction
13.7.4 Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
13.7.5 Teikoku Pharma Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Post Herpetic Neuralgia Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Post Herpetic Neuralgia Therapies Revenue
Table 3. Ranking of Global Top Post Herpetic Neuralgia Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs
Table 6. Key Players of Patches
Table 7. Key Players of Steroid Injectable
Table 8. COVID-19 Impact Global Market: (Four Post Herpetic Neuralgia Therapies Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Post Herpetic Neuralgia Therapies Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Post Herpetic Neuralgia Therapies Players to Combat Covid-19 Impact
Table 13. Global Post Herpetic Neuralgia Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Post Herpetic Neuralgia Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Post Herpetic Neuralgia Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Post Herpetic Neuralgia Therapies Market Share by Regions (2015-2020)
Table 17. Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Post Herpetic Neuralgia Therapies Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Post Herpetic Neuralgia Therapies Market Growth Strategy
Table 23. Main Points Interviewed from Key Post Herpetic Neuralgia Therapies Players
Table 24. Global Post Herpetic Neuralgia Therapies Revenue by Players (2015-2020) (Million US$)
Table 25. Global Post Herpetic Neuralgia Therapies Market Share by Players (2015-2020)
Table 26. Global Top Post Herpetic Neuralgia Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2019)
Table 27. Global Post Herpetic Neuralgia Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Post Herpetic Neuralgia Therapies Product Solution and Service
Table 30. Date of Enter into Post Herpetic Neuralgia Therapies Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 33. Global Post Herpetic Neuralgia Therapies Market Size Share by Type (2015-2020)
Table 34. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Type (2021-2026)
Table 35. Global Post Herpetic Neuralgia Therapies Market Size Share by Application (2015-2020)
Table 36. Global Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 37. Global Post Herpetic Neuralgia Therapies Market Size Share by Application (2021-2026)
Table 38. North America Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 40. North America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 41. North America Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 42. North America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 43. North America Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 44. Europe Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 46. Europe Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 48. Europe Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 50. China Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 51. China Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 52. China Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 53. China Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 54. China Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 55. China Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 56. Japan Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 58. Japan Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 60. Japan Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 64. Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 66. Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 68. India Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 69. India Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 70. India Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 71. India Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 72. India Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 73. India Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 76. Central & South America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 78. Central & South America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 80. Endo Pharmaceuticals Company Details
Table 81. Endo Pharmaceuticals Business Overview
Table 82. Endo Pharmaceuticals Product
Table 83. Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 84. Endo Pharmaceuticals Recent Development
Table 85. Depomed Company Details
Table 86. Depomed Business Overview
Table 87. Depomed Product
Table 88. Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 89. Depomed Recent Development
Table 90. Acorda Therapeutics Company Details
Table 91. Acorda Therapeutics Business Overview
Table 92. Acorda Therapeutics Product
Table 93. Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 94. Acorda Therapeutics Recent Development
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer Product
Table 98. Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 99. Pfizer Recent Development
Table 100. Mylan Company Details
Table 101. Mylan Business Overview
Table 102. Mylan Product
Table 103. Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 104. Mylan Recent Development
Table 105. Daiichi Sankyo Company Details
Table 106. Daiichi Sankyo Business Overview
Table 107. Daiichi Sankyo Product
Table 108. Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 109. Daiichi Sankyo Recent Development
Table 110. Teikoku Pharma Company Details
Table 111. Teikoku Pharma Business Overview
Table 112. Teikoku Pharma Product
Table 113. Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 114. Teikoku Pharma Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 1. Post Herpetic Neuralgia Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Post Herpetic Neuralgia Therapies Revenue
Table 3. Ranking of Global Top Post Herpetic Neuralgia Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs
Table 6. Key Players of Patches
Table 7. Key Players of Steroid Injectable
Table 8. COVID-19 Impact Global Market: (Four Post Herpetic Neuralgia Therapies Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Post Herpetic Neuralgia Therapies Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Post Herpetic Neuralgia Therapies Players to Combat Covid-19 Impact
Table 13. Global Post Herpetic Neuralgia Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Post Herpetic Neuralgia Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Post Herpetic Neuralgia Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Post Herpetic Neuralgia Therapies Market Share by Regions (2015-2020)
Table 17. Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Post Herpetic Neuralgia Therapies Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Post Herpetic Neuralgia Therapies Market Growth Strategy
Table 23. Main Points Interviewed from Key Post Herpetic Neuralgia Therapies Players
Table 24. Global Post Herpetic Neuralgia Therapies Revenue by Players (2015-2020) (Million US$)
Table 25. Global Post Herpetic Neuralgia Therapies Market Share by Players (2015-2020)
Table 26. Global Top Post Herpetic Neuralgia Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2019)
Table 27. Global Post Herpetic Neuralgia Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Post Herpetic Neuralgia Therapies Product Solution and Service
Table 30. Date of Enter into Post Herpetic Neuralgia Therapies Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 33. Global Post Herpetic Neuralgia Therapies Market Size Share by Type (2015-2020)
Table 34. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Type (2021-2026)
Table 35. Global Post Herpetic Neuralgia Therapies Market Size Share by Application (2015-2020)
Table 36. Global Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 37. Global Post Herpetic Neuralgia Therapies Market Size Share by Application (2021-2026)
Table 38. North America Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 40. North America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 41. North America Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 42. North America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 43. North America Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 44. Europe Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 46. Europe Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 48. Europe Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 50. China Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 51. China Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 52. China Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 53. China Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 54. China Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 55. China Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 56. Japan Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 58. Japan Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 60. Japan Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 64. Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 66. Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 68. India Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 69. India Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 70. India Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 71. India Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 72. India Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 73. India Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Post Herpetic Neuralgia Therapies Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Post Herpetic Neuralgia Therapies Market Share (2019-2020)
Table 76. Central & South America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Post Herpetic Neuralgia Therapies Market Share by Type (2015-2020)
Table 78. Central & South America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Post Herpetic Neuralgia Therapies Market Share by Application (2015-2020)
Table 80. Endo Pharmaceuticals Company Details
Table 81. Endo Pharmaceuticals Business Overview
Table 82. Endo Pharmaceuticals Product
Table 83. Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 84. Endo Pharmaceuticals Recent Development
Table 85. Depomed Company Details
Table 86. Depomed Business Overview
Table 87. Depomed Product
Table 88. Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 89. Depomed Recent Development
Table 90. Acorda Therapeutics Company Details
Table 91. Acorda Therapeutics Business Overview
Table 92. Acorda Therapeutics Product
Table 93. Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 94. Acorda Therapeutics Recent Development
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer Product
Table 98. Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 99. Pfizer Recent Development
Table 100. Mylan Company Details
Table 101. Mylan Business Overview
Table 102. Mylan Product
Table 103. Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 104. Mylan Recent Development
Table 105. Daiichi Sankyo Company Details
Table 106. Daiichi Sankyo Business Overview
Table 107. Daiichi Sankyo Product
Table 108. Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 109. Daiichi Sankyo Recent Development
Table 110. Teikoku Pharma Company Details
Table 111. Teikoku Pharma Business Overview
Table 112. Teikoku Pharma Product
Table 113. Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020) (Million US$)
Table 114. Teikoku Pharma Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Post Herpetic Neuralgia Therapies Market Share by Type: 2020 VS 2026
Figure 2. Drugs Features
Figure 3. Patches Features
Figure 4. Steroid Injectable Features
Figure 5. Global Post Herpetic Neuralgia Therapies Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Post Herpetic Neuralgia Therapies Report Years Considered
Figure 10. Global Post Herpetic Neuralgia Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Post Herpetic Neuralgia Therapies Market Share by Regions: 2020 VS 2026
Figure 12. Global Post Herpetic Neuralgia Therapies Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Post Herpetic Neuralgia Therapies Market Share by Players in 2019
Figure 15. Global Top Post Herpetic Neuralgia Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Post Herpetic Neuralgia Therapies Revenue in 2019
Figure 17. North America Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Endo Pharmaceuticals Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 26. Depomed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Depomed Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 28. Acorda Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Acorda Therapeutics Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 30. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Pfizer Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 32. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Mylan Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 34. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Daiichi Sankyo Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 36. Teikoku Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Teikoku Pharma Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
Figure 1. Global Post Herpetic Neuralgia Therapies Market Share by Type: 2020 VS 2026
Figure 2. Drugs Features
Figure 3. Patches Features
Figure 4. Steroid Injectable Features
Figure 5. Global Post Herpetic Neuralgia Therapies Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Post Herpetic Neuralgia Therapies Report Years Considered
Figure 10. Global Post Herpetic Neuralgia Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Post Herpetic Neuralgia Therapies Market Share by Regions: 2020 VS 2026
Figure 12. Global Post Herpetic Neuralgia Therapies Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Post Herpetic Neuralgia Therapies Market Share by Players in 2019
Figure 15. Global Top Post Herpetic Neuralgia Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Post Herpetic Neuralgia Therapies Revenue in 2019
Figure 17. North America Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Post Herpetic Neuralgia Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Endo Pharmaceuticals Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 26. Depomed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Depomed Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 28. Acorda Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Acorda Therapeutics Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 30. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Pfizer Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 32. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Mylan Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 34. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Daiichi Sankyo Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 36. Teikoku Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Teikoku Pharma Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
